The company will feature CellerateRX Surgical and the benefits of activated collagen on surgical wounds. Wound Care Innovations is a subsidiary of Wound Management Technologies, an emerging commercial stage company with its primary products in the advanced wound care market.
More articles on devices:
DOJ extends Biomet’s deferred prosecution agreement
Oppenheimer updates Globus Medical price target — 5 key notes
Are Medtronic shares undervalued at $77 per share? 7 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
